Eiger BioPharmaceuticals, Inc. 4/A
4/A · Eiger BioPharmaceuticals, Inc. · Filed Sep 15, 2016
Insider Transaction Report
Form 4/AAmended
Bramlage Charles
Director
Transactions
- Award
Stock Option (Right to Buy)
2016-03-28+25,000→ 25,000 totalExercise: $15.75Exp: 2026-03-28→ Common Stock (25,000 underlying)
Footnotes (2)
- [F1]The option vests in equal monthly installments over 12 months measured from March 28, 2016 subject to Reporting Person's continuous service status as of each such date.
- [F2]The option grant was approved by Issuer's board of directors on March 28, 2016, subject to stockholder approval of an amendment of the Issuer's 2013 Equity Incentive Plan (the "Plan") under which the option was granted. Issuer's stockholders approved the amendment to the Plan on August 29, 2016.